# TRIM40

## Overview
TRIM40 is a gene that encodes the tripartite motif containing 40 protein, which is a member of the tripartite motif (TRIM) protein family. This family is characterized by the presence of a RING finger domain, B-box domains, and a coiled-coil region, which are essential for its function as an E3 ubiquitin ligase (Kang2023TRIM40; Noguchi2011TRIM40). The TRIM40 protein plays a significant role in regulating immune responses and cellular stress by modulating the NF-κB signaling pathway, which is crucial for immune response and cell survival (Noguchi2011TRIM40). It is predominantly expressed in the gastrointestinal tract, where it helps maintain cellular homeostasis and inhibits inflammation-associated carcinogenesis (Noguchi2011TRIM40). TRIM40's interactions with proteins such as Nedd8 and IKK highlight its involvement in neddylation processes, influencing protein degradation and stability (Liu2021Tumor). Alterations in TRIM40 expression have been linked to diseases like inflammatory bowel disease and gastrointestinal cancers, underscoring its potential as a therapeutic target (Kang2023TRIM40; Noguchi2011TRIM40).

## Structure
TRIM40 is a member of the tripartite motif (TRIM) protein family, characterized by a RING finger domain, one or two B-box domains, and a coiled-coil region, which are essential for its function as an E3 ubiquitin ligase (Kang2023TRIM40; Noguchi2011TRIM40). The RING domain is crucial for the ubiquitination process, particularly in targeting proteins like ROCK1 for degradation (Kang2023TRIM40). The coiled-coil domain contributes to the protein's stability, as mutants lacking this domain are less stable (Kang2023TRIM40). The B-box domain is involved in protein interactions, as evidenced by the loss of binding affinity in TRIM40 mutants lacking this domain (Kang2023TRIM40).

TRIM40 is also involved in the neddylation of IKK, a process that inhibits NF-κB activity, which is significant in inflammation-associated carcinogenesis (Noguchi2011TRIM40). The interaction with Nedd8, a small ubiquitin-like modifier, is facilitated by the RING domain, which is essential for TRIM40's function in neddylation (Noguchi2011TRIM40). The structural domains of TRIM40 are integral to its role in regulating cellular processes, including maintaining epithelial integrity and modulating inflammatory responses (Kang2023TRIM40).

## Function
TRIM40 is a gene that encodes a protein involved in the regulation of immune responses and cellular stress. In healthy human cells, TRIM40 plays a crucial role in modulating the NF-κB signaling pathway, which is important for immune response and cell survival. TRIM40 inhibits the nuclear translocation of the NF-κB p65 subunit, a key step in NF-κB activation, by interacting with the IKK complex and promoting its neddylation. This posttranslational modification stabilizes IκB, an inhibitor of NF-κB, thereby preventing its degradation and maintaining NF-κB in an inactive state (Noguchi2011TRIM40). This regulatory function is essential for preventing excessive NF-κB activation, which is associated with inflammation and cancer development (Noguchi2011TRIM40).

TRIM40 is highly expressed in the gastrointestinal tract, including the stomach, small intestine, and large intestine, where it helps maintain cellular homeostasis by inhibiting inflammation-associated carcinogenesis (Noguchi2011TRIM40). The protein is primarily active in the cytoplasm and is involved in ubiquitination processes, influencing protein degradation and stability (Liu2021Tumor). By promoting the neddylation of IKK, TRIM40 contributes to the maintenance of cellular homeostasis and protection against inflammation in healthy cells (Noguchi2011TRIM40).

## Clinical Significance
Alterations in the expression of the TRIM40 gene have been implicated in several diseases, particularly inflammatory bowel disease (IBD) and gastrointestinal cancers. In the context of IBD, TRIM40 is identified as a pathogenic driver by disrupting intestinal barrier integrity. It is upregulated in IBD patients, leading to decreased phosphorylation of signaling factors necessary for actin formation, resulting in epithelial barrier dysfunction and chronic inflammation. This aberrant expression is linked to the pathogenesis of ulcerative colitis and Crohn's disease, as TRIM40 overexpression affects cytoskeletal regulation and cell adhesion, contributing to the disease's progression (Kang2023TRIM40).

In gastrointestinal cancers, TRIM40 is typically downregulated, which correlates with increased NF-κB activity, a pathway often implicated in inflammation and cancer. TRIM40 normally inhibits NF-κB activity through the neddylation of IKK, stabilizing IκB and preventing NF-κB activation. The downregulation of TRIM40 in cancers such as gastric, colon, and rectal cancers suggests a protective role against inflammation-associated carcinogenesis. Its reduced expression in these conditions is associated with increased cell growth and cancer progression (Noguchi2011TRIM40). These findings highlight TRIM40's potential as a therapeutic target in both IBD and gastrointestinal cancers.

## Interactions
TRIM40 is known to interact with several proteins, influencing various cellular processes. It physically binds to Nedd8, a small ubiquitin-like protein, and promotes the neddylation of IKK, a crucial regulator for NF-κB activation. This interaction inhibits NF-κB activity, which is significant in inflammation-associated carcinogenesis in the gastrointestinal tract (Noguchi2011TRIM40). TRIM40 also interacts with the IKK subunits, with a stronger interaction observed in the TRIM40(RING) variant compared to the wild type, suggesting the RING domain's role in modulating this interaction (Noguchi2011TRIM40).

In the context of antiviral immune responses, TRIM40 targets MDA5 and RIG-I, proteins involved in the RIG-I-like receptor (RLR) signaling pathways. It interacts with the CARD (caspase activation and recruitment domain) of these proteins through its coiled-coil domain, promoting their ubiquitination and subsequent degradation via the proteasome pathway. This process attenuates the innate antiviral immune responses (Zhao2017The).

TRIM40 also interacts with ROCK1, promoting its degradation, which affects actin dynamics and cell integrity. This interaction is crucial for the regulation of cytoskeletal networks and is implicated in the pathogenesis of inflammatory bowel disease (Kang2023TRIM40).


## References


[1. (Zhao2017The) Chunyuan Zhao, Mutian Jia, Hui Song, Zhongxia Yu, Wenwen Wang, Qi Li, Lining Zhang, Wei Zhao, and Xuetao Cao. The e3 ubiquitin ligase trim40 attenuates antiviral immune responses by targeting mda5 and rig-i. Cell Reports, 21(6):1613–1623, November 2017. URL: http://dx.doi.org/10.1016/j.celrep.2017.10.020, doi:10.1016/j.celrep.2017.10.020. This article has 104 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.celrep.2017.10.020)

[2. (Kang2023TRIM40) Sujin Kang, Jaekyung Kim, Areum Park, Minsoo Koh, Wonji Shin, Gayoung Park, Taeyun A. Lee, Hyung Jin Kim, Heonjong Han, Yongbo Kim, Myung Kyung Choi, Jae Hyung Park, Eunhye Lee, Hyun-Soo Cho, Hyun Woo Park, Jae Hee Cheon, Sungwook Lee, and Boyoun Park. Trim40 is a pathogenic driver of inflammatory bowel disease subverting intestinal barrier integrity. Nature Communications, February 2023. URL: http://dx.doi.org/10.1038/s41467-023-36424-0, doi:10.1038/s41467-023-36424-0. This article has 12 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-023-36424-0)

[3. (Noguchi2011TRIM40) K. Noguchi, F. Okumura, N. Takahashi, A. Kataoka, T. Kamiyama, S. Todo, and S. Hatakeyama. Trim40 promotes neddylation of ikk and is downregulated in gastrointestinal cancers. Carcinogenesis, 32(7):995–1004, April 2011. URL: http://dx.doi.org/10.1093/carcin/bgr068, doi:10.1093/carcin/bgr068. This article has 98 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/carcin/bgr068)

[4. (Liu2021Tumor) Juan Liu, Cen Zhang, Xue Wang, Wenwei Hu, and Zhaohui Feng. Tumor suppressor p53 cross-talks with trim family proteins. Genes &amp; Diseases, 8(4):463–474, July 2021. URL: http://dx.doi.org/10.1016/j.gendis.2020.07.003, doi:10.1016/j.gendis.2020.07.003. This article has 35 citations.](https://doi.org/10.1016/j.gendis.2020.07.003)